CDW Corp
CDW
136.82
+1.15
+0.85%
CDW Corp
US · CDW
#1084 by market cap
Listed 1970
136.82
+1.15
+0.85%
Live - 5344 symbols - heartbeat 64s ago
· 2026-10-08 06:38
Pre-market
131.03
-4.23%
After-hours
136.82
0.00%
Overnight
137.00
+0.13%
- Market cap
- 17.10B
- P/E (TTM)i
- 16.44
- P/Bi
- 7.00
- EPSi
- 8.08
- Div yieldi
- 1.84%
- 52W posi
- 66%
Reader sentiment
Are you bullish or bearish on CDW?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Fair
- Altman Z-Score is 2.49, in the 1.8-3.0 "grey zone".
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +6.79% YoY
Margins
- Gross margin
- 21.73%
- Operating margin
- 7.38%
- Net margin
- 4.76%
Key ratios & quality
- Enterprise valuei
- 22.12B
- Altman Z-Scorei
- 2.49
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 16.24B | 18.03B | 18.47B | 20.82B | 23.75B | 21.38B | 21.00B | 22.42B |
| Gross profit | 2.71B | 3.04B | 3.21B | 3.57B | 4.69B | 4.65B | 4.60B | 4.87B |
| Selling & admin expenses | 1.72B | 1.91B | 2.03B | 2.15B | 2.95B | 2.97B | 2.95B | 3.22B |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 987.30M | 1.13B | 1.18B | 1.42B | 1.74B | 1.68B | 1.65B | 1.66B |
| Pretax profit | 840.50M | 949.70M | 1.00B | 1.30B | 1.49B | 1.45B | 1.44B | 1.43B |
| Tax | 197.50M | 212.90M | 213.80M | 309.20M | 373.30M | 345.90M | 357.60M | 360.80M |
| Net profit | 643.00M | 736.80M | 788.50M | 988.60M | 1.11B | 1.10B | 1.08B | 1.07B |
| Basic EPS | 4 | 5 | 6 | 7 | 8 | 8 | 8 | 8 |
| Diluted EPS | 4.19 | 4.99 | 5.45 | 7.04 | 8.13 | 8.10 | 7.97 | 8.08 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 5.20B | 5.98B | 5.74B | 5.51B | 5.68B | 6.57B |
| Gross profit | 1.12B | 1.24B | 1.26B | 1.25B | 1.19B | 1.32B |
| Selling & admin expenses | 760.90M | 821.00M | 812.20M | 823.70M | 814.00M | 891.20M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 361.40M | 420.20M | 443.30M | 430.70M | 376.00M | 428.60M |
| Pretax profit | 304.00M | 364.90M | 389.40M | 369.10M | 319.00M | 372.90M |
| Tax | 79.10M | 93.70M | 98.40M | 89.60M | 83.60M | 98.50M |
| Net profit | 224.90M | 271.20M | 291.00M | 279.50M | 235.40M | 274.40M |
| Basic EPS | 2 | 2 | 2 | 2 | 2 | 2 |
| Diluted EPS | 1.69 | 2.05 | 2.21 | 2.14 | 1.82 | 2.15 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 3.80B | 4.33B | 5.95B | 6.48B | 6.56B | 6.71B | 7.37B | 8.50B |
| Cash & ST investments | 205.80M | 154.00M | 1.41B | 258.10M | 315.20M | 588.70M | 717.70M | 618.70M |
| Inventory | 454.30M | 611.20M | 760.00M | 927.60M | 800.20M | 668.10M | 605.30M | 563.40M |
| Total assets | 7.17B | 8.00B | 9.34B | 13.20B | 13.13B | 13.28B | 14.68B | 16.03B |
| Total current liabilities | 2.80B | 3.49B | 3.90B | 5.10B | 4.95B | 5.44B | 5.47B | 7.23B |
| Short-term debt | 25.30M | 413.20M | 541.00M | 412.80M | 56.30M | 613.10M | 235.80M | 1.01B |
| Long-term debt | 3.18B | 3.28B | 3.86B | 6.76B | 5.87B | 5.03B | 5.61B | 4.62B |
| Total liabilities | 6,192,500,000.00 | 7,039,100,000.00 | 8,047,600,000.00 | 12,493,700,000.00 | 11,528,200,000.00 | 11,242,100,000.00 | 12,325,700,000.00 | 13,422,100,000.00 |
| Total equity | 975.20M | 960.30M | 1.30B | 705.70M | 1.60B | 2.04B | 2.35B | 2.61B |
| Retained earnings | -1.89B | -2.02B | -1.81B | -2.57B | -1.76B | -1.53B | -1.32B | -1.27B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 7.65B | 7.84B | 7.78B | 8.50B | 8.97B | 9.68B |
| Cash & ST investments | 688.10M | 481.00M | 452.90M | 618.70M | 578.60M | 361.80M |
| Inventory | 720.20M | 761.60M | 504.70M | 563.40M | 820.60M | 981.80M |
| Total assets | 15.02B | 15.27B | 15.20B | 16.03B | 16.45B | 17.25B |
| Total current liabilities | 5.78B | 5.81B | 5.59B | 7.23B | 7.70B | 8.30B |
| Short-term debt | 230.60M | 9.50M | 9.10M | 1.01B | 1.01B | 1.01B |
| Long-term debt | 5.62B | 5.62B | 5.62B | 4.62B | 4.64B | 4.81B |
| Total liabilities | 12,695,400,000.00 | 12,798,500,000.00 | 12,657,900,000.00 | 13,422,100,000.00 | 13,898,000,000.00 | 14,812,700,000.00 |
| Total equity | 2.32B | 2.47B | 2.54B | 2.61B | 2.56B | 2.44B |
| Retained earnings | -1.40B | -1.37B | -1.31B | -1.27B | -1.33B | -1.49B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 905.90M | 1.03B | 1.31B | 784.60M | 1.34B | 1.60B | 1.28B | 1.21B |
| Depreciation & amortization | 265.60M | 267.10M | 425.60M | 191.20M | 290.60M | 270.70M | 275.30M | 295.60M |
| Free cash flow | 819.80M | 790.90M | 1.16B | 684.60M | 1.21B | 1.45B | 1.15B | 1.09B |
| Dividends paid | -139.40M | -183.40M | -219.60M | -234.80M | -282.60M | -321.50M | -332.10M | -328.60M |
| Stock buybacks / issuance | -522.30M | -657.20M | -340.60M | -1.50B | 0 | -500.00M | -500.00M | -653.00M |
| Ending cash balance | 205.80M | 154.00M | 1.41B | 258.10M | 315.20M | 588.70M | 507.70M | 618.90M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 287.20M | 155.90M | 328.30M | 433.80M | 274.80M | -55.10M |
| Depreciation & amortization | 74.90M | 73.30M | 73.30M | 74.10M | 75.10M | 75.10M |
| Free cash flow | 260.30M | 133.40M | 298.50M | 395.90M | 248.40M | -82.60M |
| Dividends paid | -82.80M | -82.30M | -81.80M | -81.70M | -81.10M | -79.80M |
| Stock buybacks / issuance | -200.10M | -150.00M | -149.90M | -153.00M | -201.00M | -343.70M |
| Ending cash balance | 475.60M | 481.20M | 453.10M | 618.90M | 579.90M | 363.10M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 65.68 | 76.14 | 69.86 | 98.72 | 96.54 | 60.58 | 49.04 | 43.02 |
| ROA %i | 9.10 | 9.72 | 9.09 | 8.77 | 8.47 | 8.36 | 7.71 | 6.95 |
| ROIC %i | 18.01 | 20.03 | 17.73 | 15.85 | 15.93 | 15.96 | 15.30 | 14.77 |
| 5-year avg ROE %i | 45.24 | 54.52 | 60.56 | 72.36 | 81.37 | 80.37 | 74.95 | 69.58 |
| EBIT margin %i | 6.09 | 6.15 | 6.27 | 6.96 | 7.26 | 7.84 | 7.86 | 7.38 |
| FCF / sales %i | 5.05 | 4.39 | 6.26 | 3.29 | 5.09 | 6.79 | 5.50 | 4.85 |
| Current ratioi | 1.35 | 1.24 | 1.53 | 1.27 | 1.33 | 1.23 | 1.35 | 1.18 |
| Quick ratioi | 1.14 | 1.02 | 1.28 | 1.02 | 1.06 | 1.03 | 1.16 | 1.04 |
| Debt / assetsi | 44.76 | 47.85 | 48.87 | 55.71 | 46.44 | 43.73 | 40.82 | 36.11 |
| LT debt / equityi | 326.43 | 355.55 | 310.33 | 983.42 | 376.82 | 254.38 | 244.66 | 183.42 |
| Interest coveragei | 6.66 | 6.96 | 7.47 | 9.60 | 7.31 | 7.40 | 7.69 | 7.28 |
| Revenue CAGR (3Y) %i | 7.73 | 9.66 | 7.58 | 8.63 | 9.61 | 5.00 | 0.28 | -1.89 |
| Net income CAGR (3Y) %i | 16.84 | 20.12 | 14.66 | 15.42 | 14.79 | 11.88 | 2.92 | -1.45 |
| FCF CAGR (3Y) %i | 63.55 | 13.53 | 18.40 | -5.83 | 15.17 | 7.85 | 19.04 | -3.43 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 48.71 | 46.39 | 43.01 | 43.02 | 44.16 | 44.01 |
| ROA %i | 7.70 | 7.45 | 7.11 | 6.95 | 6.84 | 6.64 |
| ROIC %i | 15.38 | 15.36 | 14.49 | 14.77 | 14.95 | 15.03 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 7.89 | 7.65 | 7.40 | 7.38 | 7.28 | 7.15 |
| FCF / sales %i | 4.71 | 4.66 | 4.57 | 4.85 | 4.70 | 3.66 |
| Current ratioi | 1.32 | 1.35 | 1.39 | 1.18 | 1.16 | 1.17 |
| Quick ratioi | 1.13 | 1.15 | 1.22 | 1.04 | 0.99 | 0.99 |
| Debt / assetsi | 39.91 | 37.79 | 37.88 | 36.11 | 35.19 | 34.57 |
| LT debt / equityi | 248.07 | 233.44 | 226.35 | 183.42 | 187.24 | 202.92 |
| Interest coveragei | 7.64 | 7.44 | 7.25 | 7.28 | 7.39 | 7.33 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Commercial is the largest reported line at 60.34% of revenue, across 4 reported segments.
- Education follows at 14.20%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Commercial60.34%
Education14.20%
Government12.90%
Other12.56%
Quote time 2026-10-08 06:38:26 · For reference only, not investment advice and not tailored to your situation.